SEC Form 4 · accession 0001076542-17-000103

NEXEON MEDSYSTEMS INC · NXNN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jul 1, 2017

Accepted (ET)

Oct 10, 2017 · 4:18 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001416172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
COMMON STOCK^F1	holding	—	—		—	585,000	I	See Footnote
COMMON STOCK	holding	—	—		—	30,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
OPTIONS^F2	$1.00	Jul 1, 2017	J	12,500	A	Jul 1, 2017	Jul 1, 2021	COMMON STOCK	12,500	25,000	D

F1Mr Neitzel beneficially owns the securities of the Company held by Yorkville MGB Investments, LLC. as Mr. Neitzel is the Managing Partner of Yorkville MGB Investments, LLC and in such capacity has the voting and dispositive power over the securities held by such entity.
F2Pursuant to the Director Services Agreement dated January 1, 2017, entered into between Mr. Neitzel and the Company, at the end of each 3-month period that he serves as a Director of the Company, the Company will grant to Mr. Neitzel an option (each "an Option") to purchase 12,500 shares of the Company's restricted Common Stock, at a price equal to $1.00 per share or in the alternative the price per share (the "Strike Price") of the Company's then current 409a valuation. Once established the Strike Price shall remain effective for any and all Options granted as a result of being a Director until there is a change in any future 409a valuation. Such 409a valuations shall not be retroactive for options previously granted. The term of each Option shall be for a period of four (4) years from the date of issue.